BioVaxys Technology Corp.
BioVaxys Technology Corp. (BVAXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BVAXF · as of Jun 9, 2026
Key Statistics
Explore BioVaxys Technology Corp. Data
bvaxf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bvaxf competitorsBVAXF
BICX
BIXT
BZYR
CUBT
FAMDFStock Performance
Full HistoryAbout BioVaxys Technology Corp.
BioVaxys Technology Corp. (BVAXF) is a clinical-stage biotechnology company primarily engaged in the development of innovative vaccine platforms targeting both antiviral diseases and various forms of …
what is biovaxys technology corp. · bvaxf stock overview · biovaxys technology corp. company profile · who is biovaxys technology corp. ceo · bvaxf OTC · biovaxys technology corp. headquarters · biovaxys technology corp. business segments
About Stock Overview & Key Data
BioVaxys Technology Corp. (BVAXF) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 28, 2018. As of the latest trading session, BVAXF stock price is $0.11, with a market capitalization of $3.2M. The stock has returned -61.39% over the past 12 months and -36.15% year-to-date.
In fiscal year 2024, BioVaxys Technology Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioVaxys Technology Corp. (BVAXF) stock price is $0.11. The stock is traded on OTC under the ticker symbol BVAXF. The 52-week range is $0.02 – $0.30.